The Food and Drug Administration (FDA) this week authorized a new, quick at-home COVID-19 test produced by Siemens Healthineers, as Americans grapple with a widespread shortage of testing options amid a record spike in COVID-19 cases.
The rapid antigen test is meant for individuals 14 or older to self-collect specimens. It can be used for younger persons if adults collect samples.
